Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Oral Testosterone Therapies Face Clinical Practice Difficulties, Advisory Panels Suggest

Jan 14 2018

• By Michael Cipriano

FDAEntrance_1200x675

Related Content

Oral Testosterone Therapy Jatenzo Faces CV, Sampling Tube Issues At Advisory Cmte

Jan 08 2018

Clarus' Jatenzo Suffers From Off-Label Concerns At US Advisory Committee

Jan 10 2018

Lipocine Testosterone Therapy Faces Safety, Stopping Criteria Concerns At US FDA Advisory Cmte

Jan 09 2018

Lipocine's Tlando Falls Short At US FDA Advisory Cmte Over Blood Pressure Concerns

Jan 11 2018

Related Companies

Clarus Therapeutics Holdings, Inc.

Lipocine Inc.

Additional Topics

Advisory Committees Regulation Safety Gynecology & Urology BioPharmaceutical

More from Immunological

More from Therapy Areas

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window